NCT04259580 Calgary Registry for Advanced and Therapeutic Endoscopy
| NCT ID | NCT04259580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Biliary Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2018-09-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2018-09-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the Calgary Registry for Advanced and Therapeutic Endoscopy (CReATE) is to be a high-fidelity prospective multi-centre registry. The study population consists of consecutive adult ERCP patients from September 2018 to August 2022. Informed consent is acquired for each patient. All relevant pre-procedural, procedural, peri-procedural and post-procedural data are captured in real time by a full-time third-party research assistant directly observing procedures. Outcomes are ascertained by comprehensive medical record review and patient phone interview 30 days after the index procedure. This registry also serves as a secure data collection platform for several currently recruiting prospective studies and randomized trials.
Eligibility Criteria
Inclusion Criteria: * any standard indication for ERCP, in the absence of standard contraindications; * age 18 years or over; * ability and willingness to give informed consent to be included in the registry and/or to involvement in one (or more) prospective sub-studies, or accompaniment by a surrogate who is willing and able to provide consent. Exclusion Criteria: -none other than inverses of above.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04259580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Biliary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04259580 currently recruiting?
Yes, NCT04259580 is actively recruiting participants. Contact the research team at nauzer.forbes@ucalgary.ca for enrollment information.
Where is the NCT04259580 trial being conducted?
This trial is being conducted at Calgary, Canada.
Who is sponsoring the NCT04259580 clinical trial?
NCT04259580 is sponsored by University of Calgary. The trial plans to enroll 6,000 participants.